JP Morgan cuts BridgeBio Oncology price target to $23
JP Morgan cut its BridgeBio Oncology price target to $23.00 per share from $25.00, per Benzinga ratings coverage.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.